CIPLA
Back to All Ratios
|
CIPLA Last 5 Year EPS Growth History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
EPS Growth(%) | 27.89 | 47.06 | 11.28 | 4.61 | 55.46 |
What is the latest EPS Growth ratio of CIPLA ?
Year | EPS Growth |
---|---|
Mar2025 | 27.89 |
Mar2024 | 47.06 |
Mar2023 | 11.28 |
Mar2022 | 4.61 |
Mar2021 | 55.46 |
How is EPS Growth of CIPLA Trending?
Years | EPS Growth | % Change | |
---|---|---|---|
Mar2025 | 27.89 | -40.74 | |
Mar2024 | 47.06 | 317.20 | |
Mar2023 | 11.28 | 144.69 | |
Mar2022 | 4.61 | -91.69 | |
Mar2021 | 55.46 | - |
Other Financial Ratios of CIPLA
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EPS Growth ratio of peers of CIPLA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CIPLA | ₹121,195.4 Cr | -1.7% | 2.3% | -5.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹399,249.0 Cr | -1.3% | -3.3% | 8.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹174,940.0 Cr | -1.5% | 0.8% | 42.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,618.0 Cr | -1.6% | 8.4% | 10.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹107,250.0 Cr | -3.3% | -1.4% | 9.8% | Stock Analytics | |
MANKIND PHARMA | ₹94,475.7 Cr | -3.3% | -6.1% | 3.4% | Stock Analytics |
CIPLA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CIPLA | -1.7% |
2.3% |
-5.8% |
SENSEX | 1.6% |
1% |
7% |
You may also like the below Video Courses